Phase I and pharmacokinetic study of D-verapamil and doxorubicin.

The calcium antagonist verapamil (a mixture of D- and L-racemers) is a potent modulator of the multi-drug resistance phenotype in vitro at a concentration of 6 microM. Clinical studies have shown dose-limiting toxicity of hypotension and heart block when plasma levels approach the concentrations act...

Descripción completa

Detalles Bibliográficos
Autores principales: Bissett, D., Kerr, D. J., Cassidy, J., Meredith, P., Traugott, U., Kaye, S. B.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1991
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977847/
https://www.ncbi.nlm.nih.gov/pubmed/1684909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977847/
https://www.ncbi.nlm.nih.gov/pubmed/1684909

Ejemplares similares